Here are five key notes:
1. Eight analysts gave AmSurg a short term price target of $83.63.
2. AmSurg has a higher price target estimate of $95 and a lower price estimate of $54.
3. The shares closed down 0.31 percent on Mon., Sept. 14. The company is up 15.17 percent in the last three-month period.
4. The company has a 52-week high of $87.21 and a 52-week low of $47.68.
5. AmSurg has a market cap of $3.9 billion.
More articles on surgery centers:
HCA receives ‘B+’ credit rating — 4 notes
4 new joint venture ASCs — July & August 2015
Tenet shares fall 0.7% — 5 takeaways
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.